DHR vs QCOM: Which Is the Better Buy?
Side-by-side comparison of Danaher Corporation and QUALCOMM Incorporated — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-26.
Danaher Corporation · Healthcare
$221.12
+29.6% upside to fair value
Med Conviction
Grade B
High Quality
VS
QUALCOMM Incorporated · Technology
$201.97
-21.1% upside to fair value
Med Conviction
Grade D
High Quality
QuantHub Verdict
DHR has more upside to fair value
(+29.6%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
DHR |
QCOM |
| Current Price |
$221.12 |
$201.97 |
| Fair Value Estimate |
$286.52 |
$159.42 |
| Upside to Fair Value |
+29.6%
|
-21.1%
|
| Market Cap |
$155.4B |
$212.1B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
24.8x
|
16.5x
|
| Price / Sales |
6.2x
|
4.8x
|
| Price / FCF |
28.5x
|
20.5x
|
| Revenue Growth YoY |
+5.5%
|
-4.0%
|
| Gross Margin |
58.5%
|
54.2%
|
| Operating Margin |
20.4%
|
23.2%
|
| Return on Equity |
7.7%
|
37.3%
|
| Dividend Yield |
0.65% |
1.79% |
| FCF Yield |
3.51%
|
4.88%
|
| Analyst Consensus |
Strong Buy
|
Hold
|
Investment Thesis
Danaher is a diversified life-sciences and diagnostics platform spanning three segments: Life Sciences (mass spectrometers, flow cytometry, genomics, bioprocess technologies), Diagnostics (chemistry, immunoassay, microbiology, hematology, molecular and pathology systems), and Environmental & Applied Solutions (water quality and product-identification instrumentation). The business quality is high…
Qualcomm develops foundational wireless technologies and monetizes them through two main engines: QCT, which supplies Snapdragon application processors and modems, and QTL, which licenses a standards-essential patent portfolio covering CDMA2000, WCDMA, LTE and 5G. The licensing arm and the company's entrenched position in premium Android handsets give it a genuinely high-quality business, evidenc…
Accumulation Zones
| Metric |
DHR |
QCOM |
| Zone Low |
$214.89 |
$119.56 |
| Zone High |
$243.54 |
$135.51 |
| In Buy Zone? |
Yes
|
No
|